2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$118.81+$3.78 (+3.29%)
Price as of Jun 23, 2026 5:08 PM EDT- $7.4BMarket Cap
- 115.57%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$118.81+$3.78 (+3.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 46.0M -89.41% | 434.4M +624.06% | 60.0M +125.73% | 26.6M -2.84% | |
Cost of Revenue | 1.6M +17.34% | 1.4M N/A | N/A N/A | N/A N/A | |
Gross Profit | 44.4M -89.74% | 433.1M +621.80% | 60.0M +125.73% | 26.6M -2.84% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -159.3M +15.32% | -138.1M +14.95% | -120.2M -4.80% | -126.2M +0.17% | |
Depreciation and Amortization Expense | 1.3M +54.96% | 826,000 -15.46% | 977,000 -5.51% | 1.0M +27.18% | |
Total Operating Expenses | 204.1M +12.42% | 181.6M +18.18% | 153.7M -2.72% | 158.0M +3.10% | |
Operating Profit | -158.1M -162.54% | 252.8M +369.98% | -93.7M -28.71% | -131.4M +4.39% | |
Interest Income | 28.8M +9.40% | 26.3M +76.63% | 14.9M +266.95% | 4.1M +816.48% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -598,000 0.00% | |
Interest Income and Expense and Net | 28.8M +9.40% | 26.3M +76.63% | 14.9M +330.33% | 3.5M +2,333.55% | |
Total Nonoperating Income and Expense | 27,000 -89.20% | 250,000 +224.38% | -201,000 +151.25% | -80,000 -46.31% | |
Income before Taxes | -129.3M -146.28% | 279.4M +398.35% | -93.7M -26.49% | -127.4M +1.47% | |
Income Taxes | 838,000 -80.14% | 4.2M N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -130.1M -147.29% | 275.2M +448.54% | -79.0M -38.02% | -127.4M +1.47% | |
Net Income from Continuing Operations Applicable to Common | -129.3M -146.28% | 279.4M +453.88% | -79.0M -38.02% | -127.4M +1.47% | |
Basic EPS and Net Income | -2.05 -145.86% | 4.47 +421.58% | -1.39 -46.54% | -2.60 -4.06% | |
Diluted EPS and Net Income | -2.05 -148.46% | 4.23 +404.32% | -1.39 -46.54% | -2.60 -4.06% | |
Basic Weighted Average Shares | 63.6M +3.26% | 61.6M +8.46% | 56.8M +15.74% | 49.0M +5.87% | |
Diluted Weighted Average Shares | 63.6M -2.31% | 65.1M +14.65% | 56.8M +15.74% | 49.0M +5.87% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 128.4M +32.02% | 97.2M -47.92% | 186.7M +48.50% | 125.7M +1.68% | |
Short-Term Investments | 439.0M +36.47% | 321.7M +107.67% | 154.9M +38.78% | 111.6M -45.08% | |
Cash and Cash Equivalents and Short-Term Investments | 567.4M +35.44% | 418.9M +22.63% | 341.6M +43.93% | 237.4M -27.39% | |
Total Current Assets | 577.6M -2.38% | 591.6M +66.39% | 355.6M +46.28% | 243.1M -28.66% | |
Accumulated Depreciation | 8.3M +18.19% | 7.0M +12.85% | 6.2M +18.65% | 5.3M +23.39% | |
Property and Plant and Equipment and Net | 3.9M +21.00% | 3.2M +166.95% | 1.2M -23.64% | 1.6M -12.96% | |
Total Long-Term Assets | 82.5M -42.49% | 143.4M +11,903.51% | 1.2M -23.64% | 1.6M -58.79% | |
Total Assets | 668.2M -10.28% | 744.7M +108.05% | 358.0M +44.38% | 247.9M -28.69% | |
Income Taxes Payable | 2.7M 0.00% | 2.7M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 69,000 -92.32% | |
Total Current Liabilities | 45.4M -4.13% | 47.4M +122.80% | 21.3M -31.77% | 31.2M -29.16% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Long-Term Liabilities | 19.7M -10.51% | 22.0M +1,830.94% | 1.1M 0.00% | 1.1M +842.98% | |
Total Liabilities | 53.5M -22.97% | 69.4M +226.36% | 21.3M -34.18% | 32.3M -32.21% | |
Retained Earnings | -470.7M +38.22% | -340.5M -44.69% | -615.7M +14.71% | -536.8M +31.12% | |
Total Stockholders Equity | 614.7M -8.97% | 675.3M +100.58% | 336.7M +56.15% | 215.6M -28.14% | |
Total Shares Outstanding | 62.6M +2.53% | 61.0M +5.76% | 57.7M +16.96% | 49.3M +3.14% | |
Cash Flow | |||||
Cash from Operating Activities | 57.7M -68.68% | 184.2M +362.19% | -70.2M -35.05% | -108.1M +0.25% | |
Capital Expenditures | 1.6M +17.34% | 1.4M +122.50% | 609,000 -23.40% | 795,000 -27.79% | |
Cash from Investing Activities | -49.3M -83.53% | -299.5M +662.86% | -39.3M -142.92% | 91.5M +676.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 22.9M -11.56% | 25.9M -84.83% | 170.5M +804.96% | 18.8M -85.50% | |
Financials Ratio | |||||
Gross Margin | 96.54% -3.15% | 99.69% N/A | N/A N/A | N/A N/A | |
Operating Margin | -343.63% -690.43% | 58.20% +137.29% | -156.09% -68.42% | -494.24% +7.44% | |
Return on Assets | -18.42% -136.91% | 49.91% +291.51% | -26.06% -39.07% | -42.78% +14.51% | |
Return on Equity | -20.18% -137.10% | 54.39% +290.22% | -28.59% -42.14% | -49.41% +14.06% | |
Revenue Growth | -89.41% -114.33% | 624.06% +396.36% | 125.73% +4,532.25% | -2.84% -105.37% | |
Current Ratio | 12.71 +1.83% | 12.48 -25.32% | 16.71 +114.39% | 7.80 +0.71% | |
Cash Ratio | 2.83 +37.70% | 2.05 -76.62% | 8.78 +117.63% | 4.03 +43.55% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.0003 -90.00% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.0003 -88.46% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow